paxilline has been researched along with Adenocarcinoma, Bronchiolo-Alveolar in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henderson, L; Husain, AN; Joseph, L; Krausz, T; Mackinnon, AC; Mehta, RG; Reid, ME; Salgia, R; Tretiakova, M; Yan, BC | 1 |
1 other study(ies) available for paxilline and Adenocarcinoma, Bronchiolo-Alveolar
Article | Year |
---|---|
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Biopsy; Chromosomes, Human, Pair 12; Female; Gene Dosage; Genes, erbB-1; Humans; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Proteins; Paxillin; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins | 2011 |